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Available online ▪ ▪ ▪AbstractPurpose: To determine the 1-year changes of mesopic higher order aberrations (HOAs) and contrast sensitivity (CS) after accelerated corneal
cross linking (CXL) in progressive keratoconus.
Methods: In this prospective case series, 70 eyes of 62 keratoconic patients underwent accelerated CXL (18 mW/cm2, 5 min). HOAs and CS
were measured using the OPD Scan III and CSV-1000 CS test charts under mesopic conditions before and 6 and 12 months after CXL.
Results: At 1 year, logarithmic mesopic CS in spatial frequencies of 3, 6, 12, and 18 cycles per degree (CPD) had increased by 0.05 ± 0.29
(P ¼ 0.029), 0.04 ± 0.88 (P ¼ 0.012), 0.27 ± 0.46 (P ¼ 0.172), and 0.06 ± 0.22 (P ¼ 0.020), respectively. The decrease in ocular HOAs
(0.10 ± 0.69 mm, P ¼ 0.992) [coma (0.08 ± 1.01 mm, P ¼ 0.613), trefoil (0.03 ± 0.37 mm, P ¼ 0.659), and spherical aberration (SA)
(0.10 ± 0.59 mm, P ¼ 0.743)] and corneal HOAs (0.40 ± 1.69 mm, P ¼ 0.874) [coma (0.39 ± 1.59 mm, P ¼ 0.401), trefoil (0.33 ± 2.16 mm,
P ¼ 0.368), and SA (1.27 ± 1.14 mm, P ¼ 0.354)] were not statistically significant. The correlations between mesopic CS and HOAs were weak
before and after CXL.
Conclusion: One year after accelerated CXL, CS significantly improved, but changes in HOAs were statistically insignificant. CS changes were
independent of HOAs.
Copyright © 2016, Iranian Society of Ophthalmology. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Collagen corneal cross linking (CXL) is a novel treatment
that arrests the progression of keratoconus and strengthens the
cornea through the creation of new covalent bonds.1,2 Studies
have reported halting disease progression3 and even
improvement of visual acuity and refraction4,5 after standard
CXL (3 mW/cm2, 30 min). With the accelerated protocolConflict of interest: The authors have no financial or proprietary interest in
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).(18 mW/cm2, 5 min), patient treatment and irradiation time is
reduced, total energy dose delivered to the cornea remains the
same, and comparable efficacy can be achieved.6,7
Since the quality of vision and visual function are important
parts of postoperative visual rehabilitation, evaluation of the
changes of contrast sensitivity (CS) and aberrations is of great
importance. In terms of visual quality, Lamy et al8 reported
that photopic CS measured with the PellieRobson test
improved after standard CXL. For changes in higher order
aberrations (HOAs) after CXL, some long-term studies have
reported a decrease,9,10 and some suggested no significant
change after a 1 year follow-up.11 Nonetheless, studies
regarding visual quality in low light conditions after CXL are
limited.ter accelerated corneal cross linking: A 12-month follow-up study, Journal of
sting by Elsevier B.V. This is an open access article under the CC BY-NC-ND
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CXL (18 mW/cm2, 5 min) on mesopic contrast sensitivity as a
function of visual quality. Moreover, we report the changes in
corneal and total aberrations measured with the OPD Scan III
(Nidek, Japan).
Methods
This prospective case series study was performed on 70
eyes of 62 patients who were selected through consecutive
sampling. Inclusion criteria were a diagnosis of progressive
keratoconus (at least 1.0 diopter (D) increase in maximum
keratometry (Kmax), manifest cylinder, or spherical equiva-
lent (SE) refraction, or loss of at least 2 lines of best corrected
visual acuity in the 12 months before the operation), age be-
tween 15 and 35 years, keratometry less than 55.0D, and a
central corneal thickness 450 mm. The use of hard and soft
contact lenses was stopped 3 weeks and 3 days before CXL,
respectively. Patients with any history of eye surgery or eye
disease were excluded from the study.
The Institutional Review Board of Noor Ophthalmology
Research Center reviewed the protocol and approved the
study. Written informed consent was obtained from all par-
ticipants, and the tenets of the Declaration of Helsinki were
followed in all stages of the study.Surgical techniqueAfter local anesthesia with 0.5% proparacaine hydrochlo-
ride, the epithelium of the central 9 mm of the cornea was
manually removed. Then riboflavin drops (0.1% in 20%
dextran, Streuli Pharma, Uznach, Switzerland) were instilled
on the corneal surface every 3 min for 30 min. After that, the
cornea was irradiated (370 nm, 18 mW/cm2) for 5 min using
the UVX system (PESCHKE Meditrade GmbH, Germany) at a
distance of 5 cm. At the end of this stage, the corneal surface
was irrigated with sterile balanced saline solution, a soft
bandage contact lens (Night & Day, Ciba Vision, Duluth, GA)
was placed on the eye, and levofloxacin eye drops were
instilled.
The postoperative regimen included levofloxacin eye drops
four times daily, betamethasone 0.1%, and preservative free
artificial tears (Hypromellose) as needed. The patients were
examined on days 1 and 3 after CXL. The contact lens was
removed after the epithelium was healed. Levofloxacin was
discontinued after removing the lens, and betamethasone was
continued four times daily for 1 week. If the epithelium was
not healed, daily visits continued until complete healing was
observed.
We used CSV-1000 grating charts (VectorVision, Inc.,
Greenville, OH) to measure CS under mesopic conditions. For
this purpose, daylight was blocked from the test room, and the
room illuminance was measured by a light meter (Sekonic L-
308DC, Japan) and set at 15 lux. The patient stayed in the
room for 15 min before the test to adapt to the illumination
condition of the room. Monocular CS was measured with bestPlease cite this article in press as: Hashemi H, Asgari S, Mesopic visual quality af
Current Ophthalmology (2016), http://dx.doi.org/10.1016/j.joco.2016.10.001correction in physiologically dilated eyes. The test was per-
formed without glare at a distance of 4 m.
Also, non-dilated aberrometry was performed using the
OPD Scan III, which also provided measurements of Kmax
and corneal asphericity (Q value). Ocular and corneal
HOAs including coma, trefoil, spherical aberration (SA), and
total HOAs were evaluated under mesopic conditions. All tests
were done at baseline and at 6 and 12 months after CXL.Statistical analysisThe trend of the changes of the indices was evaluated with
repeated measures analysis of covariance to adjust for the
correlation between fellow eyes. Linear regression analysis
was used to assess the contribution of each type of aberration
to the total aberrations. Pearson correlation coefficients were
determined to examine the correlations between CS and ab-
errations. In the analyses, CS values in log units were used.
The level of significance was considered 0.05.
Results
Seventy eyes of 62 keratoconus patients were enrolled in
the study, 68 (97.1%) and 67 eyes (95.7%) completed
6 months and 1 year follow-up visits, respectively. Finally 65
eyes (92.9%) had 2 follow-up data. Eight patients had bilateral
keratoconus. The mean age of the participants was
24.80 ± 3.81 years, and 69.5% of them were male. At 12
months, mean uncorrected distance visual acuity changed
from 0.33 ± 0.41 to 0.38 ± 29 logMAR (P ¼ 0.548), and mean
corrected distance visual acuity changed from 0.05 ± 0.06 to
0.15 ± 0.19 logMAR (P ¼ 0.300). In manual refraction, 48.2%
of cases had scissor reflex before CXL, and this was reduced
to 39.4% (P ¼ 0.045) at 12 months after the procedure. Mean
Kmax reduced from 46.94 ± 3.79D to 45.48 ± 2.80D
(P ¼ 0.032). Mean asphericity (Q value) changed from
0.07 ± 1.75 to 0.20 ± 1.21 (P ¼ 0.049). At the end of the
6th month, 7 eyes (10%) had corneal haze, but at 1 year, no
case of haze was observed upon slit lamp exams.
The 12-month increases in the log-C3 and log-C6 were
statistically significant (P ¼ 0.029 and P ¼ 0.012, respec-
tively). The change in log C12 was not statistically significant
despite the increasing trend (P ¼ 0.172). Log- C18 showed a
significant improvement (P ¼ 0.020) (Fig. 1).
Table 1 summarizes results of total ocular and corneal
HOAs. The decrease in ocular HOAs (0.10 ± 0.69 mm,
P ¼ 0.992) including coma (0.08 ± 1.01 mm, P ¼ 0.613),
trefoil (0.03 ± 0.37 mm, P ¼ 0.659), and SA (0.10 ± 0.59 mm,
P ¼ 0.743) were not statistically significant. Also, the de-
creases in corneal HOAs (0.40 ± 1.69 mm, P ¼ 0.874)
including coma (0.39 ± 1.59 mm, P ¼ 0.401), trefoil
(0.33 ± 2.16 mm, P ¼ 0.368), and SA (1.27 ± 1.14 mm,
P ¼ 0.354) were not statistically significant.
Pearson coefficients (r) for the correlation between CS and
ocular and corneal HOAs are presented in Table 2. Co-
efficients were less than 0.4 in all cases and statistically
insignificant.ter accelerated corneal cross linking: A 12-month follow-up study, Journal of
Fig. 1. Changes of mesopic contrast sensitivity 1 year after accelerated corneal cross linking.
Table 1
Ocular and corneal higher order aberrations (mm) at baseline and at 6 and 12
months after accelerated corneal cross linking.
Before CXL After CXL P-value*
6 months 12 months
Ocular Total HOAs 1.55 ± 0.84 1.56 ± 0.85 1.46 ± 0.81 0.992
Coma 1.24 ± 1.07 1.18 ± 0.73 1.15 ± 1.11 0.613
Trefoil 0.83 ± 0.53 0.82 ± 0.53 0.79 ± 0.48 0.659
SA 0.29 ± 0.23 0.21 ± 0.19 0.37 ± 0.71 0.524
Corneal Total HOAs 3.85 ± 6.78 3.86 ± 6.65 3.17 ± 4.22 0.874
Coma 2.68 ± 3.00 2.51 ± 1.48 2.30 ± 2.38 0.401
Trefoil 1.73 ± 4.75 1.79 ± 3.24 1.40 ± 2.55 0.368
SA 1.86 ± 7.16 1.90 ± 1.36 0.63 ± 0.86 0.354
*Comparing preoperative to 12-month changes in measurements.
HOA: higher order aberrations; SA: spherical aberration.
3H. Hashemi, S. Asgari / Journal of Current Ophthalmology xx (2016) 1e4
+ MODELDiscussion
CXL is the treatment that stops the progression of corneal
protrusion and steepening in keratoconus.12 In this procedure,
UV (Ultraviolet) irradiated riboflavin stimulates the formation
of intra and inter-fibrillar covalent bonds in the corneal
stroma13,14 which strengthen the cornea and lead to flattening
and regularization of the cornea and vision improvement.9,15
According to the findings of our study, during 12 months
after CXL, mesopic CS improved while HOAs remained un-
changed. The safety and efficacy of accelerated CXL, asTable 2
Pearson correlation coefficient between the logarithmic mesopic contrast sensitivi
corneal cross linking (CXL).
Before CXL
C3 C6 C12
Total HOAs 0.40 0.34 0.38
Coma 0.35 0.17 0.20
Trefoil 0.11 0.04 0.10
Spherical aberration 0.18 0.31 0.28
None of the correlations were statically significant (all P > 0.050).
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terms of vision and refraction outcomes and its effect on
corneal biomechanics, the two protocols have shown compa-
rable results, and accelerated CXL has been capable of halting
the progression of the disease in keratoconus patients.6,7
The studies on CS changes after CXL are limited. Lamy
et al8 reported an improvement in CS after the standard
method. Although we used a different approach and applied
accelerated CXL, a similar improvement in CS was observed.
Since the cornea is regular as an effect of surgery, CS in low
light conditions is expected to be better.
Before CXL, corneal coma was the dominant corneal HOA
(b ¼ 1.08) (Table 1) in our patients, which is in agreement
with the study by Pantanelli et al16 The HOA that showed the
most change as a result of CXL was spherical aberration
followed by coma, and neither one was statistically significant.
In the study by Caporossi et al17 at 3 months after CXL, the
mean decrease in total HOAs and coma was 0.5 mm and
0.3 mm, respectively, compared to 0.68 mm and 0.4 mm,
respectively, in our study. While the mean changes in these
two studies may seem comparable, they were statistically
significant in their study and insignificant in ours. The variance
is not reported by Caporossi et al,17 but it was high in our
study. In addition to different follow-up times, the wide range
of the variance in our sample can be responsible for the lack of
a significant change.ty and corneal higher order aberrations (HOAs) before and after accelerated
12 months after CXL
C18 C3 C6 C12 C18
0.40 0.35 0.04 0.09 0.10
0.19 0.27 0.04 0.08 0.11
0.11 0.19 0.02 0.04 0.04
0.29 0.08 0.29 0.23 0.19
ter accelerated corneal cross linking: A 12-month follow-up study, Journal of
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more than ocular HOAs, indicating that the cornea and not the
underlying layers was affected by CXL, which is in contrast to
a study by Vinciguerra et al18 who reported a substantial
decrease in ocular HOAs and believed that the decrease of the
total aberrations indicated the effect of CXL on the corneal
posterior surface. On the other hand, comparison of the 6-
month and 1-year decrease of ocular and corneal aberrations in
3 and 5 mm pupils in the study showed that despite the sig-
nificant decrease in ocular versus corneal aberrations, the
decrease in the absolute value of corneal aberrations was more
than ocular aberrations, which is clinically important. Also,
the difference in the preoperative severity of the disease can be
an important reason for the different results in these two
studies (Kmaxour study ¼ 46.94 and KmaxVinciguerra ¼ 48.08).
However, in a report by Greenstein et al,19 the changes of
aberrations measured by the Pentacam were similar to our
findings with no significant change.
Okamoto et al20 showed that CS decreases in keratoconus
patients due to increases in HOAs. Their conclusion is based on
the significant correlation between the letter-CS test and coma
and SA, but all Pearson's correlation coefficients in Okamoto
study were weak between CS at different spatial frequencies
and corneal HOAs (<0.40). Since the value of r is a better
indicator of the strength of correlations than the level of sig-
nificance, it is not very easy to comment on the effect of HOAs
on CS. In our study, CS seemed independent of HOAs. The
reason for the significant improvement of mesopic CS and
insignificant improvement of HOAs might be that CS is
affected by neural factors in addition to optical factors21 while
HOAs exclusively show optical aberrations. Another reason
could be the high variance in aberration indices and the need
for a larger sample size to show the significance of changes. On
the other hand, CS appeared independent of HOAs in short-
terms studies such as ours and the study by Wisse et al,11 but
the two parameters were related in a long-term study,10 there-
fore, the effect of HOAs on CS could develop in the long run.
The study has several limitations. Due to large standard
deviation, he sample size is small. Also, we did not have a
control group of eyes receiving the standard protocol. Such
data would enable us to perform a more comprehensive
assessment of the effect of accelerated CXL on visual quality.
Another limitation was the inclusion of eyes with corneal haze
(7 eyes) in the analysis that may affect the measurements,
although the number of eyes in this subgroup was low. In
conclusion, according to our findings, accelerated CXL
improved mesopic CS without any significant change in
HOAs. In light of the observed trend in the studied parameters,
longer follow-ups are necessary for further evaluations.
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